References
- Blomgren H. Steroid sensitivity of the response of human lymphocytes to phytohaemagglutinin and poke weed mitogen. Role of phagocytic cells. Scand. J. Immunol. 1974; 3: 655
- Blomgren H. Modification of the response of human T‐lymphocytes to phytomitogens by cocultivation with unresponsive non‐T leukocytes. Scand. J. Immunol. 1976; 5: 467
- Blomgren H. Characterization of lymphocytes which inhibit proliferation of human T‐cells exposed to lymphocyte‐derived mitogenic factors. Int. Arch. Allergy appl. Immunol. 1979; 59: 192
- Blomgren H., Edsmyr F., Näslund I. Effect of bleomycin on peripheral lymphocytes. Acta radiol. Ther. Phys. Biol. 1977; 16: 325
- Blomgren H., Strender L. ‐E., Edsmyr F. The influence of Bestatin on the lymphoid system in the human. Small molecular immunomodulators of microbial origin. Fundamental and clinical studies of Bestatin, H. Umezawa. Japan Scientific Press. 1981, (a) In press
- Blomgren H., Strender L. ‐E., Edsmyr F. Changes of the blood lymphocyte population in cancer patients treated with Bestatin, a new immunomodulator. A phase I study. Biomedicine. Europ. J. Clin. Biol. Res. 1981; 32: 178, (b)
- Blomgren H., Wasserman J., Baral E., Petrini B. Evidence for the appearance of non‐specific suppressor cells in the blood after local radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1978; 4: 249
- Blomgren H., Wasserman J., Wallgren A., Ideström K., Baral E., Petrini B. Changes in mixed lymphocyte culture (MLC) functions of peripheral lymphoid cells after radiation therapy for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 49
- Einhorn S., Blomgren H., Strander H. Interferon and spontaneous cytotoxicity in man. I. Enhancement of the spontaneous cytotoxicity of peripheral lymphocytes by human leukocyte interferon. Int. J. Cancer 1978; 22: 405
- Einhorn S., Blomgren H., Strander H. Effect of an intramuscular injection of human leukocyte interferon on blood leukocyte counts and proportions of lymphocytes forming E, EA and EAC rosettes. Int. Arch. Allergy appl. Immunol 1980; 63: 139
- Ishikawa T., Nakano I., Hirokawa I. Bleomycin treatment of the tumors of penis and scrotum. J. Urol. 1969; 102: 699
- Ishizuka M., Takayama H., Takeuchi T., Umezawa H. Activity and toxicity of bleomycin. J. Antibiot. 1967; 20: 15
- Jondal M., Holm G., Wigzell H. Surface markers on human T‐ and B‐lymphocytes. I. A large pool of lymphocytes forming nonimmune rosettes with sheep red blood cells. J. exp. Med. 1972; 136: 207
- Kawata S., Soda T., Morimitsu T., Matsumura Y., Takesue M., Motomura K., Yamada A. Treatment of the cerival oesophagus by bleomycin. Otol. Fukuoka 1969; 15: 154
- Lilliehöök B., Blomgren H. Strong stimulation of CBA‐lymphocytes in the mixed lymphocyte interaction with cells from the H‐2‐identical strain C3H. Scand. J. Immunol. 1974; 3: 627
- Oka S. A review of clinical studies of pepleomycin. Recent results in cancer research. The EORTC plenary session on cancer chemo‐ and immunophar‐macology. Springer Verlag, Berlin, Heidelberg, New York 1981, In press
- Takita T., Maraoka Y., Nakatini T., Fujii A., Umezawa Y., Naganawa H., Umezawa H. Chemistry of bleomycin and phleomycin. J. Antibiot. 1978; 31: 801